Abbott’s diabetes care VP joins Insulet
This article was originally published in Clinica
Insulet, developer of the OmniPod tubing-free insulin management system, has appointed Peter Devlin as chief commercial officer. Mr Devlin will be responsible for the Bedford, Massachusetts firm’s sales and marketing, business development, clinical research and customer care functions. Prior to joining Insulet, he was divisional vice-president of global strategic marketing for Abbott Lab’s diabetes care business.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.